Management of Prostatic Bladder Neck Obstruction

Introduction
Prostatic bladder neck obstruction(BNO) or benign prostatic hyperplasia (BPH) rarely causes symptoms before the age of 40 years. However, symptoms occur due to BNO in more than half of men in their sixties, and up to 90% of men in their seventies and eighties. Management of this condition includes issues relating to exclusion of prostate cancer, timing of intervention, and type of intervention most suitable for the individual patient.
SYMPTOMS AND COMPLICATIONS
Symptoms of BNO are best considered as being either obstructive or irritative. Obstructive symptoms include a poor pressure flow, hesitancy and a sense of incomplete emptying. Irritative symptoms include frequency, urgency, urge incontinence and nocturia. It is frequently the irritative symptoms that so adversely affect the quality of life of men. For example, the need to void four or five times per night causes chronic tiredness and lethargy. Men with BNO are at increased risk of urinary tract infection. Older men who suffer urinary tract infection should be urodynamically investigated for underlying obstructive bladder dysfunction. Unlike female cystitis, appropriate antibiotics should be provided for a full three weeks, as bacterial infection of the prostate is deep-seated. Short- course antibiotics may cause septic rebound. End-stage BNO results in acute urinary retention, which is very painful and obvious. Slow onset chronic urin ary retention is, in fact, bladder muscle failure. Chronic large residual volumes exist within the bladder. Hydro-ureteronephrosis develops with chronic renal failure if left untreated. Formation of bladder stones also complicates chronic outflow obstruction (see figure 3).
2. Diagnosis of Prostatic BNO
Accurate diagnosis is critical prior to management strategies being implemented. In clinical practice, video urodynamics is the best means of obtaining objective information. A urodynamic study is a halfhour computerised x-ray study that involves the passage of a small computer probe through the urethra into the bladder. A pressure line is also inserted per rectum. Both filling and voiding profiles are studied, with voided urinary flow correlated to bladder pressure as measured in centimetres of water pressure units. During voiding, fluoroscopy enables observation of bladder neck and prostatic urethral relaxation or obstruction. Prostate symptoms scores have been developed, but these are used more widely in pharmaceutical research than in clinical practice. As BNO is a dynamic process, and as it does not relate to prostatic size, the decision to treat and especially to operate on a man with symptoms is not based on the size of the prostate as determined by digital rectal examination. Nor should it be based on findings at cystoscopy. The relevance of prostatic size is to determine whether a patient is suitable for t r a n s u rethral resection of the prostate or alternatively an open or suprapubic prostat- ectomy approach for his benign disease.
EXCLUDING PROSTATE CANCER

Figure 2. Uroflowmetry results.
Obstructed flow due to BPH.
Many men present clinically concerned that their symptoms of benign prostatic BNO may be indicative of early prostate cancer. They should be reassured that early prostate cancer does not cause symptoms of bladder dysfunction. The decision to investigate and treat should be based on the inconvenience of symptoms rather than the fear that prostate cancer may be present. Each man who presents with symptoms of BNO should be evaluated individually for prostate cancer by means of a digital rectal examination and prostate-specific antigen (PSA) with free to total ratio determination.
WHEN TO REFER
Men with bothersome symptoms of BNO should be referred. Any man with a complication of BNO such as urinary tract infection or bladder stone formation should be evaluated urologically. All men with an elevated PSA or abnormal digital rectal examination should be referred.
3. Watchful waiting and medical management


Fig 3. Bladder Stones


Fig 4. Lateral Lobes BPH
WATCHFUL WAITING
Men with non-bothersome early symptoms of BNO may be managed expectantly. Mild symptoms do not need intervention and occasionally improve over time. Alternatively, however, many men live with disruptive urinary symptoms as they are fearful of treatments they do not completely understand. It is necessary to strike a balance between over- and under-treating BNO.
MEDICAL MANAGEMENT
Selective alpha-blockers such as prazosin (Minipress) and tamsulosin (Flomax) are able to relieve symptoms incompletely in 60-65% of patients. S i d e - e ffects include postural hypotension, nasal congestion and retrograde ejaculation due to relaxation of the bladder neck sphincter. Many men are not accepting of long-term alpha blockade as management for their symptoms. Finasteride (Proscar) is a five alpha-reductase inhibitor. It works by inhibiting the production of the male hormone dihydrotestosterone, which is thought to be responsible for prostatic enlargement. It is of limited therapeutic benefit. In prostate glands greater than 60 g, it may reduce the incidence of acute urinary retention. In a recent trial of prostate cancer prevention, finasteride was found to decrease the number of men contracting prostate cancer. However, those men who were diagnosed with prostate cancer whilst taking finasteride were found to have high-grade disease. Drugs containing pseudoephedrine will exacerbate symptoms in men with BNO. Pseudoephedrine has a sympathomimetic effect on the prostatic alpha-receptors, causing constriction and thereby i n c reasing outflow resistance. Similarly, men with high-grade BNO and secondary detrusor (bladder muscle) instability should not be treated with anticholinergic medications such as oxybutynin (Ditropan). The effect of anticholinergic medication in such patients is to diminish detrusor contractility, which results in urinary retention when significant outflow resistance is present.
4. Alternative therapies and technologies
COMPLEMENTARY OR ALTERNATIVE THERAPIES
So-called ‘alternative’ therapies for BNO have insinuated themselves into popular culture during the past two decades. They re p resent a huge worldwide market despite the absence of convincing placeboc o n t rolled trials. An article from the Journal of Urology (J Urol 2002; 168:150-154) showed a marked variability in dosage of saw palmetto between manuf acturers, and even between individual lots from the same manufacturer. Dosages ranged between 97% and 140% of the stated dose. Takers of complementary therapies believe in them as an article of faith, and often claim relief of symptoms attributable to the substance after very short periods of consumption. This indicates a significant placebo eff e c t .
ALTERNATIVE TECHNOLOGIES
A number of alternative technologies have been marketed during the past 15 years. These include transurethral needle ablation of the prostate, prostatic alcohol injection, prostatic thermotherapy and a multitude of prostatic laser therapies. These therapies have not gained widespread application because of their expense and, in many cases, lack of long-term efficacy. Holmium laser ablation of the prostate is an efficacious t reatment, but no more so than s t a n d a rd transurethral pro s t at ectomy, and it is associated with significant capital expense and re c u rring disposable costs.
5. Bladder neck incision

Figure 5. Bladder trabeculation in
response to chronic BNO.

Fig 6. TURP. Resection loop at
bladder neck.
Small tight prostates are best managed by bladder neck incisional surgery rather than formal resection of prostatic tissue. Bladder neck incisional surg ery involves an endoscopic procedure under general anaesthetic; the trigone, bladder neck and prostate gland are incised deeply in the midline to the level of the verumontanum. This relieves the obstructive effect of the prostate on the bladder neck and prostatic urethra. This is a minimal procedure with good long-term relief of symptoms for well-selected patients. Bladder neck dyssynergia occurs in men in their thirties and forties, and is due to spasticity of the bladder neck mechanism. These men have obstructive and irritative symptoms similar to those in older men with BPH. The diagnosis is made by urodynamic evaluation. This also excludes the presence of a urethral stricture. Younger men with bladder neck dyssynergia may elect to watchfully wait or undergo alpha blockade or bladder neck incisional surgery. The surgery involves a 25% occurrence of retrograde ejaculation and, hence, subfertility. Bladder neck incision surgery should not be performed on a man who wishes to retain fertility.

6. Suprapubic prostatectomy and holmium laser resection
SUPRAPUBIC PROSTATECTOMY

Figure 7. Resection to capsule.

Fig 8. Roller ball haemostasis.
bladder neck.
Very large benign prostates causing significant BNO may need to be resected via an open suprapubic approach. An assessment is made under an anaesthetic with cystourethroscopy as to the size of the transition zone. When it is estimated that an endoscopic resection would involve the removal of in excess of 60-80 g, an open procedure is best considered under the same anaesthetic. Open or suprapubic prostatectomy is the enucleation of the transition zone via a lower abdominal, horizontal skin incision. The bladder is opened and the enucleation occurs by means of resection through the urethra and the removal of the transition zone. Bladder stones can also be removed at the time of open prostatectomy. Patients are usually hospitalised for four days. They are discharged with an indwelling catheter and leg bag for one week. Suprapubic prostatectomy should not be confused with radical retropubic prostatec- tomy, which is an operation performed for early prostate cancer. Radical prostatectomy for early prostate cancer involves total removal of the prostate and its capsule. Via the suprapubic approach, only the transition zone is removed; the posterior or peripheral zone of the prostate remains in place. Patients who have suprapubic prostatectomy should therefore have ongoing screening for prostate cancer. Unlike radical prostatectomy, the neurovascular bundles that s u b s e rve erectile function are not at risk. Retrograde ejaculation will occur after suprapubic prostatectomy.
HOLMIUM LASER RESECTION
Holmium laser resection of very large benign prostate glands is also an option. Via a modified endoscope a Holmium laser fibre is passed into the prostatic urethra and is used to resect large glands with minimum blood loss. The difficulty with holmium laser resection is that large pieces of benign prostate tissue are released into the bladder. The removal of bulky tissue can be difficult, which requires an extended period of urethral instrumentation. Morcellation (grinding) devices are under investigation. Their purpose is to mince large benign fragments of prostate within the bladder, and thus facilitate their removal.
7. Contemporary transurethral resection of the prostate

Figure 9. Relief of obstruction
prostatic cavity.

Fig 10. Prostate Chips
The sub-committee of the American Urological Association that recently reviewed this matter considers contemporary transurethral resection of the prostate (TURP) to be the gold-standard therapy for prostatic BNO. Contemporary TURP refers to the operation being performed by well-trained specialist urological surgeons using continuous flow resectoscopes and three chip digital cameras (see figures 4-10). On average, a patient is admitted for 48 hours and has the procedure performed under a spinal anaesthetic. Return to sedentary work within five days is feasible. The incidence of sphincter weakness urinary incontinence is very low when an experienced surgeon perf o rms the proced u re. Vi g o rous post-operative pelvic floor training should be performed by men with mild to moderate post-operative stress incontinence. The incidence of blood transfusions is now very low. Improved haemostasis is possible using modern diathermic technology with current spray capability. The TURP syndrome is now an uncommon occurrence during endoscopic prostatic resection. This syndrome refers to the excess absorption of glycine irrigating fluid during the operation, usually via large prostatic venous plexuses. This syndrome may cause c a rdiovascular and electro l y t e disturbances during the intraoperative and immediate postoperative period. It is more likely to occur when very large prostate glands are subject to endoscopic resection. Management strategies include cardiovascular support and correction of electrolyte disturbances. C o n t e m p o r a ry transure t h r a l prostatectomy is now a lowmorbidity procedure. Following relief of prostatic obstruction, the patient experiences an immediate impro v ement in urinary flow, but irritative symptoms such as frequency, urgency and nocturia may take three, and on occasion, six months to settle. The resolution of these symptoms depends on the degree of pre-operative detrusor instability that developed secondary to the chronic outflow obstruction. Occasionally, anticholinergic medications such as oxybutynin are necessary for a varying period of time. Fifteen per cent of men with chronic detrusor instability prior to surgery continue to have symptoms post-operatively and may require chronic oxybutynin medication. Their obstructive symptoms, however, will have been relieved. Transurethral prostatectomy does not cause erectile dysfunction, as it is not associated with damage to the neurovascular complex that proceeds to the erectile bodies. Retrograde ejaculation is inevitable and men should be warned of this event. Men still have a normal feeling of orgasm; ejaculatory fluid is passed with the first post-ejaculatory void. TURP removes the periurethral adenoma, now called the transition zone of the p rostate. It does not protect from prostate cancer and men should continue to have a digital rectal examination and PSA determination on an annual basis.
CONCLUSION
Prostatic BNO is a common condition in men aged 50 years and over, and it adversely affects quality of life. Accurate diagnosis and judicious treatment will result in a good clinical outcome.
 
 
Disclaimer: This page may contain images unsuitable for viewing by young children